Artículos por temáticas

Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders

Hopp SC.

J Neurosci Res. 2021 Jan;99(1):141-162. doi: 10.1002/jnr.24585. Epub 2020 Jan 29.

Computational investigation on the effect of Oleuropein aglycone on the α-synuclein aggregation

Borah P, Sanjeev A, Mattaparthi VSK.

J Biomol Struct Dyn. 2021 Mar;39(4):1259-1270. doi: 10.1080/07391102.2020.1728384. Epub 2020 Feb 24.

Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis

Yeung AWK, Tzvetkov NT, Georgieva MG, Ognyanov IV, Kordos K, Jóźwik A, Kühl T, Perry G, Petralia MC, Mazzon E, Atanasov AG.

Antioxid Redox Signal. 2021 Feb 10;34(5):402-420. doi: 10.1089/ars.2019.7952. Epub 2020 Mar 9.

Quantitative T(1) mapping of the substantia nigra using phase-sensitive inversion recovery sequence at 3.0-T: a healthy volunteer study

Fujiwara Y, Hirai T, Ueda T, Kumazoe H, Ito S.

Acta Radiol. 2021 Feb;62(2):243-250. doi: 10.1177/0284185120920806. Epub 2020 May 7.

Impact of Fiberoptic Endoscopic Evaluation of Swallowing Outcomes and Dysphagia Management in Neurodegenerative Diseases

Tye CB, Gardner PA, Dion GR, Simpson CB, Dominguez LM.

Laryngoscope. 2021 Apr;131(4):726-730. doi: 10.1002/lary.28791. Epub 2020 Jun 16.

The role of magnetic fields in neurodegenerative diseases

Riancho J, Sanchez de la Torre JR, Paz-Fajardo L, Limia C, Santurtun A, Cifra M, Kourtidis K, Fdez-Arroyabe P.

Int J Biometeorol. 2021 Jan;65(1):107-117. doi: 10.1007/s00484-020-01896-y. Epub 2020 Mar 20.

Glutamatergic inputs to GABAergic interneurons in the motor thalamus of control and parkinsonian monkeys

Albaugh DL, Huang C, Ye S, Paré JF, Smith Y.

Eur J Neurosci. 2021 Apr;53(7):2049-2060. doi: 10.1111/ejn.14763. Epub 2020 May 16.

Application of Nanomaterials in Neurodegenerative Diseases

Cui W, Fu W, Lin Y, Zhang T.

Curr Stem Cell Res Ther. 2021;16(1):83-94. doi: 10.2174/1574888X15666200326093410.

Voluntary movements cause beta oscillations increase and broadband slope decrease in the subthalamic nucleus of parkinsonian patients

Belova EM, Semenova U, Gamaleya AA, Tomskiy AA, Sedov A.

Eur J Neurosci. 2021 Apr;53(7):2205-2213. doi: 10.1111/ejn.14715. Epub 2020 Mar 20.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of Parkinsonism

Abdelwahab S, Elsebay SAG, Fouli Gaber M, Abdel-Hafez SMN.

J Cell Physiol. 2021 Jan;236(1):440-457. doi: 10.1002/jcp.29872. Epub 2020 Jun 17.

Anticholinergic Medications

Ghossein N, Kang M, Lakhkar AD.

2021 May 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.

Effect of different types of exercises on psychological and cognitive features in people with Parkinson's disease: A randomized controlled trial

Gobbi LTB, Pelicioni PHS, Lahr J, Lirani-Silva E, Teixeira-Arroyo C, Santos PCRD.

Ann Phys Rehabil Med. 2021 Jan;64(1):101407. doi: 10.1016/j.rehab.2020.05.011. Epub 2020 Oct 6.

Altered white matter microarchitecture in Parkinson's disease: a voxel-based meta-analysis of diffusion tensor imaging studies

Suo X, Lei D, Li W, Li L, Dai J, Wang S, Li N, Cheng L, Peng R, Kemp GJ, Gong Q.

Front Med. 2021 Feb;15(1):125-138. doi: 10.1007/s11684-019-0725-5. Epub 2020 May 26.

Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases

Gao J, Liao Y, Qiu M, Shen W.

Neuroscientist. 2021 Feb;27(1):58-72. doi: 10.1177/1073858420914509. Epub 2020 Apr 3.